focus -WSS

focus

author：fashion 2025-10-01 15:38:59 - browse：37

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Obesity now affects over 1 billion people worldwide, study finds

WSS

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

RSV vaccines may be linked to small increased risk of developing GBS

American woman, child freed after being kidnapped in Haiti last month

Maui's cultural, historic landmarks damaged in the devastating wildfires

South Korea throws huge K

Pfizer highlights cancer drugs it thinks could reignite investor interest

entertainment

focus

focus

Sports medicine is finally prioritizing gender equality

In same hospitals, Black patients receive fewer opioids than white patients

Hepatitis C has a cure — but many Americans still lack access to it

Wegovy trial has doctors encouraged over new possibilities

Continuity nursing helped my family in our darkest PICU moments

RSV vaccines may be linked to small increased risk of developing GBS

Affirmative action in medical school literally saved lives

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Hepatitis C has a cure — but many Americans still lack access to it

How to fix the rural physician shortage in the U.S.

knowledge

In search for therapies for solid tumors, companies turn to claudin

Change Healthcare cyberattack outage could last weeks

Obesity now affects over 1 billion people worldwide, study finds

Emergent cuts jobs, executive role in business shake

Anavex keeps shifting the goalposts in its clinical trials

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Wikipedia

explore

knowledge

hotspot